logo

For the Inventor, By the Inventor

Gladbach, Germany

Miltenyi Biotec, Gmbh


USPTO Granted Patents = 58



Trademarks = 24

Forward Citations = 623

Loading Chart...
Loading Chart...

91 inventors (with patents filed for the assignee):

goldMedal Stefan Miltenyi (29 out of 62 patents)

silverMedal Eiad Kabaha (11 out of 20 patents)

bronzeMedal Andreas Bosio (10 out of 21 patents)

4.  Winfried Schimmelpfennig (8 out of 17 patents)

5.  Mario Assenmacher (7 out of 14 patents)

6.  Holger Lantow (7 out of 15 patents)

7.  Martin Biehl (6 out of 24 patents)

8.  Christian Dose (6 out of 7 patents)

9.  Jürgen Schulz (5 out of 6 patents)

10.  Alexander Scheffold (4 out of 5 patents)

11.  Volker Nolle (4 out of 6 patents)

12.  Juergen Schulz (4 out of 10 patents)

13.  Andrzej Dzionek (4 out of 7 patents)

14.  Ralf-Peter Peters (4 out of 42 patents)

15.  Thomas Rockel (3 out of 4 patents)


Core Competencies:
Sterile Connector
Immunotherapy
Cell Separation
Electroporation
Chimeric Antigen Receptor
Centrifugation Techniques
Genetically Modified T Cells
Nanomatrices
Antigen-Specific T Lymphocytes
Cell Detection
Humanized Antibodies
Cardiomyocyte Subpopulations

58 patents:

1. 11633584 - Sterile connector (2023-04-25),
2. 11531031 - Single use tubing set for making genetically modified donor cells for reinfusion into a patient (2022-12-20),
3. 11339407 - Systems and methods for point/center-of-care immunotherapy (2022-05-24),
4. 11073515 - Method for photobleaching stained cells (2021-07-27),
5. 11053470 - Disposable cartridge for electroporation (2021-07-06),
6. 10890580 - Reversible cell labelling with conjugates having two releasable binding sites (2021-01-12),
7. 10617720 - Chimeric antigen receptor specific for tumor cells (2020-04-14),
8. 10513687 - Method for polyclonal stimulation of T cells by flexible nanomatrices (2019-12-24),
9. 10407486 - Ligating BDCA-2 protein with BDCA-2 specific antibody for detecting or modulating dendritic cells (2019-09-10),
10. 10336799 - Fibroblast growth factor muteins with increased activity (2019-07-02),
11. 10287543 - Process and device for isolating cells from biological tissue (2019-05-14),
12. 10273504 - Method and device for cell modification (2019-04-30),
13. 10273295 - Chimeric antigen receptor specific for SSEA4 antigen (2019-04-30),
14. 10201606 - Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseases (2019-02-12),
15. 10197561 - Cell detection with conjugates having an enzymatically releasable detection moiety (2019-02-05),
Miltenyi Biotec GmbH is a leading provider of products and services for biomedical research and cellular therapy. The company specializes in developing solutions for cell separation, analysis, and culture, as well as clinical-grade cell manufacturing. With a strong focus on innovation and collaboration, Miltenyi Biotec aims to advance scientific discoveries and improve patient outcomes.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
58 Patents

#1 in Gladbach

#966 in Germany

#12,003 in the World

...
Gladbach, Germany

Miltenyi Biotec, Gmbh

Forward Citations = 623

91 inventors:

goldMedal Stefan Miltenyi (29 out of 62 patents)

silverMedal Eiad Kabaha (11 out of 20 patents)

bronzeMedal Andreas Bosio (10 out of 21 patents)

4.  Winfried Schimmelpfennig (8 out of 17 patents)

5.  Mario Assenmacher (7 out of 14 patents)

Please report any incorrect information to support@idiyas.com
Loading…